A Long-term, Single-Arm, Open-label, Multicenter Trial to Evaluate Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

Principal Investigator

Dr Sithara Ramdas

Contact us

Email: childrensresearch@ouh.nhs.uk

IRAS number

1004782